What are the guidelines for transcutaneous pacing?

Transcutaneous Pacing Guidelines

Transcutaneous pacing is recommended as the first-line temporary pacing modality for symptomatic bradycardia unresponsive to medical therapy, particularly in emergency situations where immediate intervention is needed before more definitive therapy can be instituted. 1, 2

Indications for Transcutaneous Pacing

Class I Indications (Strongly Recommended):

• Hemodynamically unstable patients with symptomatic bradycardia unresponsive to medical therapy 3, 4
• Ventricular asystole 3
• Patients requiring temporary pacing while awaiting transvenous pacing or permanent pacemaker placement 2

Class II Indications (Reasonable to Consider):

• Sinus bradycardia (rate less than 50 bpm) with symptoms of hypotension (systolic blood pressure less than 80 mm Hg) unresponsive to drug therapy 3
• Symptomatic bradycardia not responsive to atropine 3
• Bilateral bundle branch block (alternating BBB or RBBB with alternating LAFB/LPFB) 3
• New or indeterminate age bifascicular block (RBBB with LAFB or LPFB, or LBBB) with first-degree AV block 3
• Mobitz type II second-degree AV block 3

Technical Considerations

Electrode Placement and Application:

• Apply transcutaneous pacing patches to clean, dry skin 5
• Anterior patch placement: left precordium (cardiac apex) 5
• Posterior patch placement: left infrascapular region or right anterior chest 5
• Ensure proper skin contact to minimize impedance 5, 6

Pacing Parameters:

• Initial output: Start at 40-80 mA and increase until consistent capture is achieved 5, 6
• Higher current may be required in patients with:
  • Emphysema
  • Pericardial effusion
  • Positive pressure ventilation 5
• Rate setting: Typically 60-80 beats per minute, adjusted based on clinical response 5, 6

Confirmation of Capture:

• Electrical capture: Widened QRS complex followed by distinct ST segment and broad T wave on ECG 5
• Mechanical capture: Must be confirmed by assessing arterial pulse or waveform 2, 5
• Consider alternative ECG leads if pacing artifact obscures QRS complex 2
• Use additional monitoring methods (arterial pressure, pulse oximetry) when ECG assessment is difficult 2

Patient Management

Pain Management:

• Transcutaneous pacing is associated with significant discomfort 2
• Provide adequate sedation and analgesia for conscious patients 5, 7
• Consider alternative pacing methods for prolonged pacing needs 3

Monitoring Requirements:

• Continuous cardiac monitoring until pacing is no longer necessary 2
• Regular assessment of capture threshold 5, 6
• Monitoring for complications including skin burns or tissue damage 7

Special Populations

Pediatric Considerations:

• Transcutaneous pacing is effective in children across all age groups 8
• Smaller electrode sizes may be necessary for children weighing less than 15 kg 8
• Mean threshold current requirements are similar to adults (approximately 50-60 mA) 8

Limitations and Complications

Limitations:

• Variable capture reliability, particularly in cardiac arrest situations 9
• Significant patient discomfort limiting prolonged use 2, 7
• Difficulty confirming mechanical capture due to large pacing artifact 2

Complications:

• Pain and discomfort 2, 7
• Skeletal muscle contraction 7
• Potential for skin burns with prolonged use 7

Transition to Definitive Therapy

• Transcutaneous pacing should be considered a bridge to more definitive therapy 3, 4
• For patients likely to require prolonged pacing, transition to transvenous or permanent pacing is recommended 3
• Transcutaneous pacing is particularly valuable in patients receiving thrombolytic therapy, reducing the need for vascular interventions 3